Noul Co. Ltd. (376930)

Overview

Noul Co., Ltd. is a pioneer in the healthcare industry, focusing on in vitro and remote diagnostic technologies on a global scale since its inception in 2015. Based out of Yongin-si, South Korea, Noul has dedicated itself to advancing medical diagnostics through innovation, particularly by harnessing the power of artificial intelligence (AI). Its primary mission is to make diagnostic services more accessible and efficient, regardless of the geographical and societal barriers that patients might face.

Products and Services

• miLab: AI-based Blood Diagnostic Medical Device
  

  miLab stands at the forefront of Noul's product line, representing a groundbreaking medical device that streamlines the diagnostic process. It is engineered to automate the preparation, imaging, and analysis of blood samples, incorporating AI to ensure precision and speed. This device aims to revolutionize how blood diagnostics are conducted, making it an indispensable tool in modern healthcare settings.

• Malaria Diagnostics
  

  Noul offers specialized diagnostics for malaria, employing cutting-edge technology to facilitate rapid and accurate detection of the disease. This service underscores the company's commitment to combating global health challenges and epitomizes its role in enhancing disease diagnosis in regions where malaria is prevalent.

• Blood Cell Morphology Analysis
  

  Understanding the significance of blood cell morphology in health and disease, Noul provides comprehensive analysis services. These services are essential for diagnosing a wide range of conditions, from anemias to infections, leveraging sophisticated imaging and AI analysis to deliver detailed results.

• Cancer Morphology
  

  With a keen focus on cancer diagnostics, Noul offers morphology analysis services that assist in the identification and understanding of various cancer types. Through meticulous examination and sophisticated diagnostic techniques, Noul aids in the critical early detection and management of cancer.

• Immunohistochemistry Services
  

  Noul extends its diagnostic expertise to include immunohistochemistry, a crucial technique in understanding cellular markers and diagnosing diseases. These services are particularly vital in the field of oncology, where specific marker identification can guide treatment decisions and prognostic assessments.